Macrogenics (MGNX) Other Operating Expenses (2021 - 2026)

Macrogenics (MGNX) has 6 years of Other Operating Expenses data on file, last reported at $9.5 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 76.48% year-over-year to $9.5 million in Q1 2026; TTM through Mar 2026 was $40.1 million, a 157.59% increase from a year earlier, with the FY2025 full-year figure at $36.0 million, up 192.78% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $9.5 million, down from $10.1 million in the prior quarter.
• Over the last five years, Other Operating Expenses for MGNX reached as high as $11.6 million in Q3 2025 and fell as low as $48000.0 in Q1 2022.
• Historically, Other Operating Expenses has averaged $4.3 million across 5 years, with a median of $3.1 million in 2022.
• Across the five-year window, Other Operating Expenses surged 10818.18% in 2022 and sank 90.9% in 2023, its largest moves.
• Year by year, Other Operating Expenses stood at $1.8 million in 2022, then sank by 90.9% to $163000.0 in 2023, then soared by 3268.1% to $5.5 million in 2024, then soared by 84.24% to $10.1 million in 2025, then declined by 5.78% to $9.5 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $9.5 million in Q1 2026, $10.1 million in Q4 2025, and $11.6 million in Q3 2025.